Herold Advisors, Inc.
Source: SEC Form 13F · as of Mar 2026Herold Advisors, Inc. holds 17 biotech & pharma companies tracked by BioSniper, totaling $36.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$36.2M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 10,193 | $9.4M |
| ABBVAbbVie Inc. | 35,090 | $7.6M |
| MRKMerck & Co., Inc. | 31,656 | $3.8M |
| JNJJOHNSON & JOHNSON | 15,405 | $3.8M |
| BMYBRISTOL MYERS SQUIBB CO | 35,977 | $2.2M |
| PFEPFIZER INC | 75,030 | $2.1M |
| ABTABBOTT LABORATORIES | 12,502 | $1.3M |
| AMGNAMGEN INC | 3,624 | $1.3M |
| GILDGILEAD SCIENCES, INC. | 6,908 | $963K |
| PMPhilip Morris International Inc | 5,088 | $841K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,329 | $630K |
| CAHCardinal Health Inc. | 2,750 | $581K |
| IQVIQVIA Holdings Inc. | 3,200 | $546K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 8,351 | $461K |
| GMOptec International, Inc. | 4,800 | $358K |
| ZTSZoetis Inc. | 2,480 | $293K |
| EBSEmergent BioSolutions Inc. | 10,000 | $83K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.